Human leukocyte antigens B8-DRB1*03 in pediatric patients with nephropathia epidemica caused by Puumala hantavirus

Pediatric Infectious Disease Journal

Volumn 23, Issue 10, 2004, Pages 959-961

  Mustonen, Jukka ^a,b   Huttunen, Niilo Pekka ^c   Partanen, Jukka ^d   Baer, Maija ^b   Paakkala, Antti ^a,b   Vapalahti, Olli ^e   Uhari, Matti ^f  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c Central Hospital of Central   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acute nephritis; Hantavirus infection; HLA antigens; Immune response; Nephropathia epidemica

Indexed keywords

HLA B8 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAPLOTYPE; HLA TYPING; HUMAN; KIDNEY DISEASE; MALE; PREVALENCE; PRIORITY JOURNAL; PUUMALA VIRUS; GENETICS; IMMUNOLOGY; PRESCHOOL CHILD; VIRUS HEMORRHAGIC FEVER;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HLA-B8 ANTIGEN; HUMANS; MALE; PUUMALA VIRUS;

EID: 16544367368     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000141737.45047.99     Document Type: Article

References (18)

1. Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3: 653-661.
2. Van Epps HL, Terajima M, Mustonen J, et al. Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med. 2002;196: 579-588.
3. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol. 1996;46:369-378.
4. Valtonen M, Kauppila M, Kotilainen P, et al. Four fatal cases of nephropathia epidemica. Scand J Infect Dis. 1995;27:515-517.
5. Lähdevirta J. Nephropathia epidemica in Finland: a clinical, histological and epidemiological study. Ann Clin Res. 1971;3(suppl. 8):S1-S154.
6. Settergren B. Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia. Rev Infect Dis. 1991;13:736-744.
7. Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A. Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis. 1999;31:427-435.
8. Lautala P, Uhari M. Epidemic nephropathy in children. Am J Dis Child. 1991;145:1181-1183.
9. Ahlm C, Settergren B, Gothefors L, Juto P. Nephropathia epidemica (hemorrahagic fever with renal syndrome) in children: clinical characteristics. Pediatr Infect Dis J. 1994;13:45-49.
10. Mustonen J, Huttunen NP, Brummer-Korvenkontio M, Vaheri A. Clinical picture of nephropathia epidemica in children. Acta Paediatr. 1994;83:526-529.
11. Mäkelä S, Mustonen J, Ala-Houhala I, et al. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(-308) G/A polymorphism. J Infect Dis. 2002;186:843-846.
12. Mustonen J, Partanen J, Kanerva M, et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 1998;47:277-279.
13. Alper CA, Kruskall MS, Marcus-Bagley D, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989;321:708-712.
14. Malkovsky M. HLA and natural history of HIV infection. Lancet. 1996;348:142-143.
15. Lenzi M, Frisoni M, Mantovani V, et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood. 1998;15:2062-2066.
16. Yoo KH, Choi Y. Haemorrhagic fever with renal syndrome in Korean children. Pediatr Nephrol 1994;8:540-544.
17. Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis. 1996;173:1297-1303.
18. Armstrong LR, Bryan RT, Sarisky J, et al. Mild hantaviral disease caused by Sin Nombre virus in a four-year-old child. Pediatr Infect Dis J. 1995;14:1108-1110.